XIX World Congress on Parkinson’s Disease and Related Disorders 2011

The latest research and updates on the etiology, pathogenesis, potential diagnostic markers and treatment modalities of Parkinson’s Disease and its related disorders.

Topics will include:

1. ADHD/ OCD/ Tourette Syndrome
2. Allied health
3. Alpha-synuclein
4. Animal models
5. Autonomic nervous system
6. Biological markers, early diagnostic tests
7. Chorea/ Huntington’s chorea
8. Cognition
9. Cortex
10. Cortico-basal degeneration
11. Deep brain stimulation
12. Dementia/ Dementia with Lewy bodies/ PD-related dementia
13. Depression in PD
14. Diagnosis: diagnostic tools
15. Diagnosis: premotor diagnosis
16. Dyskinesia
17. Dystonia
19. Drug-induced movement disorders
19. Drugs: COMT and MAO inhibitors
20. Drugs: L-dopa, dopamine agonists
21. Drugs: new drugs
22. Drugs: disease-modifying drugs
23. Drugs: unwanted side effects
24. Economics
25. Extra-basal ganglia sites: cortex/ thalamus
26. Familial/genetic forms of parkinsonism
27. Frontotemporal dementia with parkinsonism
28. Gait disorders, falls
29. Genetics, genomics and proteomics
30. Gene therapy
31. Imaging
32. Impulse control disorders
32. Inclusion bodies
34. Inflammation
35. Iron, copper, manganese
36. Multiple stem Atrophy/ Shy-Drager/ Parkinson’s Plus
37. Myoclonus
38. Neuropathology/ neurodegeneration/ neuronal death
39. Neurophysiology
40. Neurotoxicity/ toxic proteins
41. Olfaction
42. Parkin, LRRK2/ PINK
43. Parkinson’s Disease
44. Pharmacogenetics
45. Post-traumatic movement disorders
46. Protein aggregates, tau
47. Protein processing/ ubiquitin/ proteasome
48. Psychogenetic movement disorders
49. Psychiatric symptoms in movement disorders
50. Psychosis in PD
51. Quality of life
52. Rehabilitation
53. Sleep disturbances/ RLD/ PLMD
54. Stem cells/ pigmented retinal epithelial cells
55. Stiff person syndrome
56. TMS
57. Therapeutic drug monitoring
58. Transplantation
59. Tremor
60. Wilson’s disease